MAPT and Alzheimer disease: The current findings indicate that an increase in IIV longitudinally is associated with a reduction in CBF in key brain regions implicated early in the progression of AD pathogenesis, suggesting that IIV is associated with subtle cerebrovascular changes among individuals who are presumed to be on the AD continuum given they are p-tau/Aβ+.